» Articles » PMID: 36142455

Vesicular Glutamate Release from Feeder-FreehiPSC-Derived Neurons

Abstract

Human-induced pluripotent stem cells (hiPSCs) represent one of the main and powerful tools for the in vitro modeling of neurological diseases. Standard hiPSC-based protocols make use of animal-derived feeder systems to better support the neuronal differentiation process. Despite their efficiency, such protocols may not be appropriate to dissect neuronal specific properties or to avoid interspecies contaminations, hindering their future translation into clinical and drug discovery approaches. In this work, we focused on the optimization of a reproducible protocol in feeder-free conditions able to generate functional glutamatergic neurons. This protocol is based on a generation of neuroprecursor cells differentiated into human neurons with the administration in the culture medium of specific neurotrophins in a Geltrex-coated substrate. We confirmed the efficiency of this protocol through molecular analysis (upregulation of neuronal markers and neurotransmitter receptors assessed by gene expression profiling and expression of the neuronal markers at the protein level), morphological analysis, and immunfluorescence detection of pre-synaptic and post-synaptic markers at synaptic boutons. The hiPSC-derived neurons acquired Ca-dependent glutamate release properties as a hallmark of neuronal maturation. In conclusion, our study describes a new methodological approach to achieve feeder-free neuronal differentiation from hiPSC and adds a new tool for functional characterization of hiPSC-derived neurons.

Citing Articles

Optimization of Transcription Factor-Driven Neuronal Differentiation from Human Induced Pluripotent Stem Cells for Disease Modelling and Drug Screening.

Servetti M, Caramia M, Parodi G, Loiacono F, Nano E, Biddau G Stem Cell Rev Rep. 2025; .

PMID: 39888571 DOI: 10.1007/s12015-025-10845-4.


Human pluripotent stem cells as a translational toolkit in psychedelic research .

Salerno J, Rehen S iScience. 2024; 27(5):109631.

PMID: 38628967 PMC: 11019282. DOI: 10.1016/j.isci.2024.109631.


Disease phenotypic screening in neuron-glia cocultures identifies blockers of inflammatory neurodegeneration.

Birkle T, Willems H, Skidmore J, Brown G iScience. 2024; 27(4):109454.

PMID: 38550989 PMC: 10973195. DOI: 10.1016/j.isci.2024.109454.


Glutamate secretion by embryonic stem cells as an autocrine signal to promote proliferation.

Teng L, Qin Q, Zhou Z, Zhou F, Cao C, Yang J Sci Rep. 2023; 13(1):19069.

PMID: 37925518 PMC: 10625544. DOI: 10.1038/s41598-023-46477-2.


hiPSC-Derived Cells as Models for Drug Discovery 2.0.

Ofir R Int J Mol Sci. 2023; 24(6).

PMID: 36982801 PMC: 10053529. DOI: 10.3390/ijms24065727.


References
1.
Pistollato F, Carpi D, Mendoza-de Gyves E, Paini A, Bopp S, Worth A . Combining in vitro assays and mathematical modelling to study developmental neurotoxicity induced by chemical mixtures. Reprod Toxicol. 2021; 105:101-119. PMC: 8522961. DOI: 10.1016/j.reprotox.2021.08.007. View

2.
Fruscione F, Valente P, Sterlini B, Romei A, Baldassari S, Fadda M . PRRT2 controls neuronal excitability by negatively modulating Na+ channel 1.2/1.6 activity. Brain. 2018; 141(4):1000-1016. PMC: 5888929. DOI: 10.1093/brain/awy051. View

3.
Marcoli M, Cervetto C, Paluzzi P, Guarnieri S, Raiteri M, Maura G . Nitric oxide-evoked glutamate release and cGMP production in cerebellar slices: control by presynaptic 5-HT1D receptors. Neurochem Int. 2006; 49(1):12-9. DOI: 10.1016/j.neuint.2005.12.010. View

4.
Lewerenz J, Maher P . Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence?. Front Neurosci. 2016; 9:469. PMC: 4679930. DOI: 10.3389/fnins.2015.00469. View

5.
Page S, Sripathy S, Farinelli F, Ye Z, Wang Y, Hiler D . Electrophysiological measures from human iPSC-derived neurons are associated with schizophrenia clinical status and predict individual cognitive performance. Proc Natl Acad Sci U S A. 2022; 119(3). PMC: 8784142. DOI: 10.1073/pnas.2109395119. View